Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2022 Dec 6;51(8):985–994. doi: 10.1097/MPA.0000000000002143

Associations Between Poor Oral Hygiene and Risk of Pancreatic Cancer

A Meta-analysis of Observational Studies

Shuai Xu 1, Hui-lan Wang 1, Chao Xia 1, Jun Lv 1, Gang Zhang 1
PMCID: PMC9835655  PMID: 36607944

Objectives

Epidemiological studies have reported the association of poor oral hygiene, especially periodontal disease, and tooth loss with the risk of pancreatic cancer (PC). However, these studies have yielded inconsistent results. Therefore, this systematic review and meta-analysis aimed to investigate the relationship between oral disease and PC.

Methods

We systematically searched the PubMed, Embase, and Cochrane Library databases for English literature since inception through May 2021. We used relative risks, hazard ratios, or odds ratios to measure the association between oral disease and PC. A fixed- or random-effects model was applied to evaluate pooled risk estimates, and sensitivity and subgroup analyses were performed to identify sources of heterogeneity and pooled estimation.

Results

We identified 17 relevant observational studies involving 1,352,256 participants. Notably, oral disease correlated significantly with PC (hazard ratio [HR], 1.32; 95% confidence interval [CI], 1.13–1.54). In subgroup analyses, subjects with periodontal disease (HR, 1.38; 95% CI, 1.12–1.71) had a higher risk of developing PC than those with tooth loss (HR, 1.19; 95% CI, 0.97–1.46).

Conclusions

The results suggest that subjects with oral disease may face a significant and independent risk of PC. However, the mechanisms linking oral disease and PC are uncertain, and additional investigations of this correlation are warranted.

Key Words: pancreatic cancer, oral hygiene, periodontal disease, meta-analysis


Pancreatic cancer (PC) is a fatal malignant tumor with an overall 5-year survival rate of approximately 5%, with very poor prognosis.1 Pancreatic cancer ranks as the fourth leading cause of cancer-related deaths in the United States and seventh leading cause of cancer deaths worldwide.2 The latest data from the Global Cancer Observatory showed that PC accounted for almost as many deaths (466,000) as cases (496,000) in 185 countries in 2020,3 with the highest incidence rates in Europe and North America. Although advancements in treatment, such as chemotherapy, radiation, and immunotherapy, have improved the overall short-term survival, the long-term survival and prognosis remain poor. This is mainly attributable to the fact that most patients with PC are diagnosed at a later stage of disease because of the lack of specific symptoms, which otherwise prompt an early investigation.4 Pancreatic cancer is extremely difficult to treat, and little is known about its risk factors; therefore, further studies are warranted for better understanding of its etiology and pathogenesis.

It is reported that some modifiable factors, including smoking, alcohol abuse, obesity, as well as diet,57 and some nonmodifiable factors, such as genetics, diabetes mellitus, and age, can increase the risk of PC.8,9 Accordingly, other risk factors, such as conditions related to oral disease, are thought to correlate with an increased risk of PC.1012 Oral hygiene might potentially affect nutritional status and microbial flora. In addition, emerging evidence suggests that the mechanism of periodontal disease (PD) in the pathogenesis of PC is associated with a chronic inflammatory process.13 For instance, the bacteria involved in PD stimulate the production of inflammatory mediators and secretion of various cytokines, ultimately promoting cell proliferation, mutagenesis, oncogene activation, and angiogenesis,14 indicating that PD may be a considered a high-risk factor for PC.1517 However, conclusions from the abovementioned studies are inconsistent and, in some cases, contradictory. Therefore, a better understanding of the etiology of PC, interactions between risk factors, and new approaches to prevention and treatment are required to improve the outcomes of this disease.

A meta-analysis involving the systematic summarization of existing data may provide more credible evidence than a relatively small sample from a single study. For this reason, we used a meta-analysis to comprehensively summarize the existing relevant data and investigate the hypothesis that oral disease may be an independent predictor of PC. In addition, this report aimed to discuss the important role of chronic periodontal inflammation in the development of PC.

MATERIALS AND METHODS

Search Strategy

The literature search strategy was based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.18 The PubMed, Embase, and Cochrane Library databases were searched systematically to identify relevant studies from the earliest available data until May 2021. The following Medical Subject Headings terms and key words were used as search terms: oral disease, oral hygiene, periodontal disease, periodontitis, tooth loss, tooth miss, alveolar bone loss, periodontal pocket, clinical attachment loss, pancreatic cancer, pancreatic neoplasms, pancreas cancer, and pancreas neoplasms (Supplemental Table 1, http://links.lww.com/MPA/A978). The search was restricted to studies conducted on human subjects and those published in English.

Eligibility Criteria

Studies were considered eligible for analysis if they met the following criteria: (1) an observational study design, including cross-sectional, case-control, and cohort studies and (2) studies that contained the minimum information necessary to estimate the relative risks (RRs), hazard ratios (HRs), or odds ratios (ORs) to measure the association between oral disease and PC. In cases of multiple reports on the same population or subpopulation, either the most recently published study or the study with the longest follow-up period was included.

Data Extraction

Two independent reviewers (S.X. and H.L.W.) selected the studies for inclusion and extracted the data. Any discrepancies or uncertainties were resolved by consensus after rechecking the source and discussing with a third reviewer (G.Z.). The following information was extracted from all included publications: first author, publication year, country, study design, sample size, sex, age, follow-up duration (in years), exposure assessment, PC criterion, adjusted HR/RR values and corresponding 95% confidence intervals (CIs), covariates in the fully adjusted model, and study quality.

Quality Assessment

The Newcastle-Ottawa Quality Assessment Scale was used to evaluate the quality of the retrieved case-control and prospective studies.19 These comprehensive tools have been partially validated as measures of the quality of observational studies in meta-analyses. Both tools yield scores according to the following system: low quality, 0–4; moderate quality, 5–7; and high quality, 8–11.20 A higher score indicates better methodological quality.

Statistical Analysis

Relative risks or HRs and ORs were used as the measure of the association between oral disease and PC. Statistical heterogeneity among studies was evaluated using Cochran Q test and quantified using the I2 metric. This parameter was used to establish whether it was reasonable to assume a consistent estimate of HR across studies.21 For the Q statistic, a P value less than 0.10 was considered to indicate statistically significant heterogeneity. For the I2 statistic, the following cutoff points were used: less than 30% (little or no heterogeneity), 30% to 75% (moderate heterogeneity), and more than 75% (high heterogeneity).22 When the heterogeneity among studies was high, a random-effects model was used to calculate the pooled estimates. Otherwise, a fixed-effects model was applied. Forest plots were produced to visually assess the HR estimates and corresponding 95% CIs across studies; this was done for individual studies as well as for all studies combined.

To explore the potential causes of and test possible associations for heterogeneity, subgroup analyses based on the adjusted HR/RRs were conducted according to geographical region, study design, sample size, sex, exposure assessment, length of follow-up, and methodological quality. Furthermore, potential publication bias was assessed using Begg rank correlation test and Egger linear regression method.23,24 Funnel plots were also generated to assess the publication bias. In cases of possible publication bias, a trim-and-fill algorithm strategy was used to correct the asymmetry of the funnel plot.25 Finally, a sensitivity analysis was performed by sequentially eliminating one individual study from the meta-analysis at a time using the Metaninf algorithm in STATA software (version 12.0; STATA Corporation, College Station, Tex). All reported P values were 2-tailed, and a P value less than 0.05 was considered statistically significant.

RESULTS

Literature Screening

A detailed illustration of the study selection process is presented in Figure 1. Briefly, the preliminary literature search identified 937 potentially relevant articles. After evaluating the titles and abstracts, 366 studies were selected for a full-text review. Finally, 17 articles containing data from 1,352,256 participants were included in this meta-analysis.

FIGURE 1.

FIGURE 1

Flowchart demonstrating the process from the identification of eligible studies to their final inclusion.

Study Characteristics

The characteristics and adjusted covariates of each study are listed in Table 1. All analyzed studies were published between 2003 and 2020 and contained analyzed data collected from studies conducted between 1963 and 2016. The reports included 1 case-control study29 and 16 prospective cohort studies.12,17,2628,3040 Across all studies, the reported ages of participants ranged from 18 to 86 years. Seven, 6, and 4 studies were primarily conducted in the United States, Asia, and Europe, respectively. All studies reported adjusted HR/RR/OR values, and only one study did not adjust the analysis for potential confounders. All cases of PC had been pathologically or cytologically confirmed. An association of PD with PC was reported in 14 studies, whereas 3 demonstrated an association of tooth loss with PC. The parameters of PD exposure varied among studies and included the gingival bleeding index, alveolar bone loss, and clinical attachment loss. The overall quality of the studies was high, with no remarkable limitations (Supplemental Table 2, http://links.lww.com/MPA/A978).

TABLE 1.

Characteristics of the Observational Studies on Oral Hygiene and PC Included in This Meta-analysis

Study, Year Country Study Design n Sex Age, y Followed Oral Disease Criterion Dental Status Pancreatic Criterion Risk Estimates (95% CI) Adjustments Quality
Hujoel et al,26 2003 United States Cohort study 11,328 adults M: 4469
F: 6859
25–74 1971, 1975
F-up 1992
A medical and dental examination with a periodontal pocket and attachment loss PD Diagnosed with pancreas obtained (ICD-9 157.0–157.9) OR, 1.77 (0.85–3.67) Age, sex High
Stolzenberg et al,12 2003 Finland Prospective cohort study 29,104 males M: 29,104 50–69 1985–1997 Questionnaires Tooth loss Diagnosed with pancreas obtained coded ICD-9 157 HR, 1.63 (1.09–2.46) Age, smoking history, education, urban living, and height Low
Michaud et al,27 2007 United States Prospective cohort study 51,529 White males M: 51,529 40–75 1986 to January 31, 2002 Questionnaire PD Diagnoses of PC were confirmed with medical records (95%) RR, 1.64 (1.19–2.26) Age, smoking history, profession, race, geographic location, physical activity, diabetes, BMI, height, history of cholecystectomy, nonsteroidal anti-inflammatory drug use, multivitamin use, dietary intake of fruits and vegetables, vitamin D, calcium, sucrose, and total calories Low
Michaud et al,28 2008 United States Prospective cohort study 48,375 males M: 48,375 40–75 1986
to January 31, 2004
Radiographs examined to assess bone loss in all posterior teeth present PD Medical records or pathology reports HR, 1.54 (1.16–2.04) Age, race, physical activity, history of diabetes, alcohol, body mass index, geographic location, height, calcium intake, total caloric intake red meat intake, fruit and vegetable intake, and vitamin D score, smoking history Low
Hiraki et al,29 2008 Japan Case-control study 5240 cancer and 10,480 noncancer Case:
F: 2541
M: 2699;
Control:
F: 5082
M: 5398
18–79 January 2001 to November 2005 A self-administered questionnaire Tooth loss Cancers were defined according to the ICD, pancreas (C25) OR, 1.33 (0.57–3.10) Age, sex, smoking and drinking status, vegetable and fruit intake, BMI, and regular exercise High
Arora et al,30 2010 Swedish Prospective cohort study 15,333 twins F: 55% M: 45% 38–77 1963–2004 Questionnaire PD Physician and pathologist reports HR, 2.06 (1.14–3.75) Sex, age, education, employment, number of siblings, smoking status, smoking status of partner, alcohol status, diabetes, and BMI High
Ahn et al,31 2012 United States Prospective cohort study 12,605 periodontitis M: 6046
F: 6559
17 and older 1988 to 2006 Periodontal attachment loss and pocket depth PD Pancreatic cancer coded by the ICD-10-C25 RR, 4.56 (0.93–
22.29)
Age, sex, smoking status, education, race/ethnicity, and BMI High
Ansai et al,32 2013 Japan Prospective cohort study 657 M: 277
F: 420
80 1998–2010 A medical questionnaire Tooth loss Cancer deaths coded by the ICD-10 HR, 0.96 (0.83–1.11) Sex and smoking status, total cholesterol, serum albumin, fasting serum glucose, BMI, physical activity, place of residence High
Wen et al,33 2014 China Nationwide cohort study 51,791 periodontitis and 96,375 gingivitis
patients
M: 73,810
F: 71,086
Older
than 20
January 1, 1997 to December 31, 2010 Diagnosed with periodontitis (ICD-9-CM codes 523.3 and 523.4) PD Cancer diagnosis (ICD-9-CM codes 140–194, 200–208) HR, 1.15 (0.75–1.78) Sex, age, and the presence of comorbidities High
Huang et al,34 2016 Sweden Cohort study 19,924 M: 9862
F: 10,062
≥15 1973–1974 to 2012 Clinical examination of dental plaque PD PC of death register (ICD-7 to ICD-9: 157; ICD-10: C25) HR, 1.30 (0.70–2.30) Age, sex, and attained calendar period in 10-year-intervals, tobacco use, alcohol consumption, and area of residence High
Chang et al,35 2016 Taiwan Retrospective cohort study 139,805 with PD and 75,085 without PD PD:
M: 63,958
F: 75,847
Without PD:
M: 38,515
F: 36,570
Mean age, 39.4 vs 46.7 1998–2005 Diagnosis of PD (ICD-9-CM code: 523) PD Diagnosis issued by the hospital with confirmation by laboratory results, histology, and/or diagnostic imaging HR, 1.55 (1.02–2.33) Age, sex, diabetes, hypelipidemia, allergies, viral hepatitis, peptic ulcer, pancreatitis, COPD, and alcohol-related conditions High
Michaud et al,36 2016 United States Prospective cohort study 19,933 males M: 19,933 40–75 1986 to 2012 Questionnaire PD Medical records were obtained from physicians/hospitals HR, 1.26 (0.82–1.93) Age, race, alcohol use, physical activity, history of diabetes, body mass index, geographical location, height, NSAID use Low
Nwizu et al,37 2017 United States Prospective cohort study 65,869 females F: 65,869 54–86 1999 and 2003 to September 2013 Questionnaire PD International Classification of Diseases for Oncology (ICD-O-2) HR, 0.89 (0.67–1.18) None Low
Chou et al,38 2018 China Retrospective cohort 67,672 with PD M: 34,395
F: 33,277
≥18 January 1, 2001, to December 31, 2010 A diagnostic code of periodontitis (ICD-9, 5234 and 5235) PD Pancreatic cancer was diagnosed using the ICD for Oncology (C25) HR, 0.90 (0.47–1.75) Age, sex, comorbidities, Charlson Comorbidity Index score, medication, and socioeconomic status High
Heikkilä et al,39 2018 Finland Cohort study 68,273 F: 58%
M: 42%
Mean age, 43 January 1, 2001, and December 31, 2002, continued until December 31, 2013, or death Data from dental visits within a period starting 2 y after the first visit PD Cancer defined by topology (ICD-O-3): pancreas (C25) RR, 2.28 (1.31–3.98) Calendar time, age, sex, and socioeconomic status, number of teeth, dental treatments, oral health indices, need of periodontal treatment, and diabetes High
Gerlovin et al,40 2019 United States Prospective cohort study 3088 F: 3088 33–81 2007–2016 Questionnaire PD Pancreatic adenocarcinoma (ICD-10 codes C25.0–25.9, histology code 8140). HR, 1.77 (0.57–5.49) Age, smoking status, pack-years of smoking, alcohol consumption, BMI, and type 2 diabetes Low
Lee et al,17 2020 Korea Prospective cohort study 150,774 M: 91,855
F: 58,919
40–79 January
2002 to December 2015
A medical health examination program PD Pancreatic cancer coded by the ICD-10 classification (C25) HR, 0.98 (0.85–1.14) Age, smoking history, profession, race, geographic location, physical activity, history
of diabetes, BMI, height, history of cholecystectomy, nonsteroidal anti-inflammatory drug use, multivitamin use
High

BMI indicates body mass index; COPD, chronic obstructive pulmonary disease; F-up, follow-up; ICD, International Classification of Diseases; NSAID, nonsteroidal anti-inflammatory drug.

Meta-analysis

The adjusted HR/RR/ORs from the 17 studies were pooled and analyzed as presented in Figure 2. Overall, oral disease exhibited a statistically significant correlation with PC (HR, 1.32; 95% CI, 1.13–1.54) and remained an independent risk factor for PC even after adjusting for confounders such as smoking, alcohol consumption, age, and sex. In other words, our analysis strongly suggests that participants with tooth loss or PD face a significantly increased risk of PC.

FIGURE 2.

FIGURE 2

Meta-analysis of observational studies on oral hygiene and PC in a random-effects model. The horizontal lines correspond to the study-specific HR/RR/OR and 95% CI. The areas of the squares reflect the study-specific weights.

As we detected moderate statistical heterogeneity among the studies (P = 0.001, I2 = 60.6%), we used the random-effects model to merge HR values. In addition, Begg test (P = 0.537), Egger test (P = 0.002), and a funnel plot revealed minor publication bias (Fig. 3). Therefore, we applied the trim-and-fill method to re-evaluate the pooled risk estimates, which yielded a result of “no trimming performed; data unchanged.” Sensitivity analyses conducted during the sequential elimination of each study did not alter the overall risk estimate, which ranged from 1.13 (95% CI, 1.09–1.29) to 1.54 (95% CI, 1.45–1.63; Fig. 4). These sensitivity analyses indicate that the results of this meta-analysis are stable and reliable.

FIGURE 3.

FIGURE 3

Begg funnel plot of publication bias in the included studies. Funnel plot of the included studies for publication bias. Each point represents a separate study for the indicated association.

FIGURE 4.

FIGURE 4

Sensitivity analysis of the meta-analysis of the correlation between oral hygiene and PC. The HR/RR/OR and 95% CI were determined by omitting each study from the pool of eligible studies concerning the link between oral hygiene and PC.

Subgroup Analysis

To examine the stability of the studies, we conducted subgroup analyses based on several factors. When we stratified subjects by poor oral hygiene condition, we found that those with PD (HR, 1.38; 95% CI, 1.12–1.71) faced a slightly higher risk of developing PC compared with those with tooth loss (HR, 1.19; 95% CI, 0.97–1.46; Table 2). In a sex-specific subgroup analysis, we found that 4 male-pooled studies demonstrated an increased risk of PC (HR, 1.53; 95% CI, 1.29–1.82), whereas 2 female-pooled studies showed only a marginally increased risk of PC (HR, 1.00; 95% CI, 0.60–1.66). In terms of geographical distribution, the incidence rate of PC in European countries is significantly higher (HR, 1.76; 95% CI, 1.36–2.27) than that of the United States (HR, 1.40; 95% CI, 1.07–1.82) and Asia (HR, 1.02; 95% CI, 0.91–1.14). Overall, our subgroup analyses based on various factors revealed that subjects with either tooth loss or PD have a high risk of developing PC.

TABLE 2.

Results of Subgroup Analyses Included in This Meta-analysis

Group No. Studies Pooled HR (95% CI) P (Heterogeneity) I2, %
All studies 17 1.32 (1.13–1.54) 0.000 62.3
Assessment
 Periodontal disease 14 1.36 (1.13–1.63) 0.002 60.8
 Missing tooth 3 1.21 (0.81–1.82) 0.047 67.4
Study design
 Prospective cohort study 16 1.32 (1.12–1.54) 0.000 64.6
 Case-control study 1 1.33 (0.57–3.10) 0.000 0.0
Location
 America 7 1.40 (1.07–1.82) 0.034 55.9
 Europe 4 1.76 (1.36–2.27) 0.525 0.0
 Asian 6 1.02 (0.91–1.14) 0.344 11.1
Sex
 Male 4 1.53 (1.29–1.82) 0.786 0.0
 Female 2 1.00 (0.60–1.66) 0.248 25.0
No. participants
 >10,000 15 1.37 (1.15–1.62) 0.002 59.9
 <10,000 2 1.00 (0.75–1.33) 0.294 9.3
Length of follow-up, y
 >10 13 1.27 (1.07–1.50) 0.001 64.3
 <10 4 1.51 (1.13–2.01) 0.292 19.7
Study quality
 High 11 1.28 (1.05–1.55) 0.007 59.1
 Low and moderate 6 1.36 (1.07–1.73) 0.039 57.2

DISCUSSION

We reviewed the literature and identified 17 studies reporting the association between PD and PC risk. Our results showed that oral disease is associated with an increased risk of PC (HR, 1.32; 95% CI, 1.13–1.5), with no evidence of heterogeneity across studies and no evidence of publication bias. Even after adjusting the results for smoking, alcohol, sex, age, and education, subjects with tooth loss or PD had a significantly increased risk of PC.

Our results concurred with those of previous studies that support a positive association between PD and PC risk.41,42 Maisonneuve et al42 pooled 8 studies in a meta-analysis and reported that PD (HR, 1.74; 95% CI, 1.41–2.15) and edentulism (HR, 1.54; 95% CI, 1.16–2.05) seem to be associated with PC, even after adjusting for common risk factors. In the updated Health Professionals Follow-up Study analyses, PD was associated with PC in smoking-adjusted multivariable models (HR, 1.54; 95% CI, 1.16–2.04) and for smoking-related cancers among nonsmokers that included an elevated risk of PC (HR, 1.57; 95% CI, 0.98–2.50).36 In a study by Arora et al,30 the risk estimate for PD (RR, 2.06; 95% CI, 1.14–3.75) was fully adjusted for known risk factors and was also similar to the summary risk estimates obtained from our meta-analysis.

Pancreatic cancer and PD share many common risk factors, including tobacco smoking, heavy alcohol drinking, obesity, metabolic syndrome, diabetes, and allergy. Smoking has been considered the most important environmental risk factor for PC.43 In Finland, a significant association between tooth loss and PC (174 cases) was reported in a cohort study (between 1985 and 1997) of male smokers (n = 529,104).12 Michaud et al27 found an association between PC (216 cases) and history of PD (48,375 males), with the association being higher among nonsmokers after adjustment for age, smoking, diabetes, body mass index, and several dietary factors. Moreover, excessive alcohol consumption is considered the main cause of chronic pancreatitis, which is a known risk factor for PC.44 For instance, the most recent meta-analysis found that low and moderate alcohol consumption was not associated with PC risk; however, in those with high alcohol consumption, there was a 15% increased risk of PC.45 After extensive adjustment for recognized confounders (age, sex, race, alcohol, education), our meta-analysis results suggest that PD is a risk factor for PC mortality and may play a role in the development of PC, independent of other known risk factors.

How can PD, which occurs in the oral cavity, be linked to cancer development at a distant site such as the pancreas? Periodontal disease is a chronic inflammatory disease affecting the supporting structures of the teeth, which is induced by pathogenic bacteria.10 Several possible mechanisms have been proposed. Oral infection may result in inflammation at distant sites, and chronic inflammation is known to induce carcinogenesis.35 Given the lack of strong evidence that specific pathogenic oral bacteria are found in the pancreatic tumor tissue or tumor microenvironment, it is likely that the oral microbiome influences PC risk through systemic impact on immune function and inflammation, which is plausible, given the association between inflammation and PC. Several biological mechanisms could explain the link between periodontitis and cancer risk, including systemic inflammation, immune dysregulation due to chronic periodontitis, and alteration of cancer signaling pathways by oral pathogens. Elevated systemic markers of inflammation in patients with chronic periodontitis include interleukin 6, tumor necrosis factor α, and fibrinogen. In addition, periodontopathogenic bacteria may enter circulation and induce inflammatory response at distant sites.

Alternatively, emerging evidence suggests that the host's immunity and inflammatory responses to oral bacteria, rather than the bacteria themselves, cause PD.46 Oral bacteria is involved in producing carcinogenic metabolic by-products from oral exposures. Both N-nitroso and acetaldehyde compounds are etiological factors for PC. Oral bacteria convert ethanol to acetaldehyde, a carcinogen; they also activate carcinogenic N-nitroso compounds present in tobacco smoke and some foods and catalyze their endogenous formation from these and other sources. Moreover, oral nitrate-reducing bacteria play a key role in the formation of carcinogenic N-nitroso compounds in the stomach. Oral nitrate reduction is responsible for nearly 80% of the total nitrite exposure by an individual; it is also directly correlated with urinary N-nitroso compound levels.47 The endogenous formation of nitrosamines has been found to be substantially higher among individuals with poor oral hygiene than among those with good oral hygiene. The importance of periodontal infections to PC is further strengthened by pilot intervention trials indicating that periodontal therapy can prevent and reverse cancer adverse events, for example, reducing the pathogenesis of distal inflammatory processes, such as the pathogenesis of cancer.

In addition to inducing inflammation, some oral bacteria have been shown to activate carcinogens contained in alcohol and cigarettes. For example, studies have shown the capability of nonpathogenic Neisseria and streptococci, which are both commonly present in the mouth, in converting ethanol into acetaldehyde, which is an established carcinogen.48,49 Furthermore, certain common oral bacteria, including Streptococcus mitis and Veillonella dispar, were found to activate nitrosamine in cigarette smoke.50 Although some mechanisms have been proposed, the cause of PC in relation to periodontitis remains unclear. Therefore, further studies are required to confirm the relationship between periodontitis and PC in future investigations.

In addition to PD, tooth loss has been considered a potential risk factor for PC. For instance, a meta-analysis that pooled four studies on edentulism suggested that edentulism is associated with PC, even after adjusting for common risk factors (RR, 1.54; 95% CI, 1.16–2.05).51 In this regard, tooth loss is of notable interest because it can be an indicator of severe periodontitis. However, it can also be related to several other conditions or factors; thus, tooth loss may not be an accurate or appropriate measure of periodontitis/PD. Furthermore, tooth loss may be a surrogate measure of high bacterial load on teeth because of poor dental hygiene practices and a possible marker for the presence of gastrointestinal flora, which may be related to the risk of PC.52 In a large cohort study, a statistically significant 2-fold increase in the risk of PC was observed for those who had dental plaque covering more than one-third of the tooth surface versus no dental plaque at the baseline examination among those with at least 10 teeth remaining.34 In addition, it was reported that as edentulous and dentate individuals with missing teeth change their eating habits,53 they may avoid certain nutritious foods because of the difficulty in chewing and would opt for high-calorie, high-fat foods instead.54 Because there is a reduced ability to pulverize foods to small particle sizes during the masticatory process, deglutition and digestion of larger particles may take longer durations, which might adversely affect the intestinal absorption of nutrients and increase the risk of PC.55 Ultimately, the changes in eating habits due to tooth loss and consequent chronic malnutrition predispose these individuals to an increased risk of death. For instance, Hujoel et al26 showed that edentulous individuals had an elevated risk of death from PC (OR, 1.90; 95% CI, 0.95–3.81). However, Michaud et al27 found that the association between incident tooth loss and PC was further attenuated when PD was added to the model, suggesting that tooth loss may not be an independent risk factor. The results of this meta-analysis showed that tooth loss has a slight association with the increased risk of PC, after analyzing 3 large cohort studies (OR, 1.21; 95% CI, 0.81–1.82). The findings from studies that evaluated tooth loss were less consistent, with only a few of the associated risk estimates reaching statistical significance, and had no general evidence of a trend in risks related to the number of teeth lost.

In addition, incidence rates of PC are higher in high Human Development Index countries especially in Europe and North America.3 Understanding the geographic distribution of PC is important in assessing disease burden and in identifying high-risk populations. Differences in incidence rates are strikingly apparent and as high as 20-fold between the populations with the highest rate of 9.7 per 100,000 in Europe and the lowest rate with a reported incidence of 0.5 per 100,000 in South Asia. A further study showed that it ranges from 7.3 to 7.4 per 100,000 population in North America and Western Europe to 1.0 per 100,000 population in Middle Africa and South Central Asia.56 In this meta-analysis, 7 studies were conducted in the United States, 4 in Europe, and 6 in Asia, providing a good geographical representation and further supporting the generalizability of the association. The result suggests that the United States (HR, 1.40; 95% CI, 1.07–1.82) and Europe (HR, 1.78; 95% CI, 1.36–2.27) have a higher risk of PC than Asia (HR, 1.02; 95% CI, 0.91–1.14). Therefore, providing support and confirming previous studies that Europe and North America have higher incidence rates of PC. With regard to geographic distribution, future studies should therefore assess the relationship of health behaviors and the impact of the physical environment with the spatial distribution of PC.

Despite its strengths, our study has several limitations of note. First, our meta-analysis was based on observational studies. Although typical and major risk factors, such as smoking and alcohol consumption, were considered in most included studies with adjusted groups, it is difficult to control for these confounding factors in epidemiological studies. Second, although all PC cases were histopathologically confirmed, information about the stage or severity or detailed kinds of PC was not available. Third, heterogeneity was detected among the studies included in our meta-analysis. This factor should not be ignored even if it is a common limitation among meta-analyses of general association studies. In our case, the heterogeneity remained even when we performed subgroup analyses to verify the data. Fourth, the assessment tools used to identify PD differed among the included studies. Fifth, the numbers of remaining teeth were examined in subjects after the occurrence of cancer. Although it is unlikely that cancer caused tooth loss, this limitation should be considered when interpreting the results. Thus, the abovementioned limitations may affect our conclusions.

In summary, the available evidence points to an association between PD and subsequent tooth loss with PC. Prevention and treatment of periodontitis may thus have substantial implications for public health in terms of prevention and early diagnosis, reducing the morbidity and mortality associated with PC. The potential link between oral disease and PC remains unclear but could be related to alterations in the oral microbiome. Further studies are warranted to confirm such association and investigate potential underlying mechanisms, such as identifying the pathogenic bacteria and/or fungi, or other unmeasured factors related to dental plaque and oral mucosal lesions.

Supplementary Material

pancreas-51-985-s001.pdf (175.7KB, pdf)

Footnotes

The authors declare no conflict of interest.

This study was supported by grants from the characteristic technology item of major clinical innovation of the Second Affiliated Hospital of Army Medical University (2018jslc0022).

Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.pancreasjournal.com).

Contributor Information

Shuai Xu, Email: 714877110@qq.com.

Chao Xia, Email: xiafeiyu0929@126.com.

Jun Lv, Email: shohofu@163.com.

Gang Zhang, Email: 2577928221@qq.com.

REFERENCES

  • 1.McGuigan A Kelly P Turkington RC, et al. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24:4846–4861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.GBD 2017 Pancreatic Cancer Collaborators . The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4:934–947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sung H Ferlay J Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. [DOI] [PubMed] [Google Scholar]
  • 4.Zeeshan MS, Ramzan Z. Current controversies and advances in the management of pancreatic adenocarcinoma. World J Gastrointest Oncol. 2021;13:472–494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mizuno S Nakai Y Isayama H, et al. Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patients. Pancreas. 2014;43:1014–1017. [DOI] [PubMed] [Google Scholar]
  • 6.Kuzmickiene I Everatt R Virviciute D, et al. Smoking and other risk factors for pancreatic cancer: a cohort study in men in Lithuania. Cancer Epidemiol. 2013;37:133–139. [DOI] [PubMed] [Google Scholar]
  • 7.Rahman F Cotterchio M Cleary SP, et al. Association between alcohol consumption and pancreatic cancer risk: a case-control study. PLoS One. 2015;10:e0124489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Solomon S Das S Brand R, et al. Inherited pancreatic cancer syndromes. Cancer J. 2012;18:485–491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Xie WZ Jin YH Leng WD, et al. Periodontal disease and risk of bladder cancer: a meta-analysis of 298476 participants. Front Physiol. 2018;9:979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Tominari T Ichimaru R Yoshinouchi S, et al. Effects of O-methylated (−)-epigallocatechin gallate (EGCG) on LPS-induced osteoclastogenesis, bone resorption, and alveolar bone loss in mice. FEBS Open Bio. 2017;7:1972–1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Stolzenberg-Solomon RZ Dodd KW Blaser MJ, et al. Tooth loss, pancreatic cancer, and Helicobacter pylori. Amer J Clin Nutr. 2003;78:176–181. [DOI] [PubMed] [Google Scholar]
  • 13.Gholizadeh P Eslami H Yousefi M, et al. Role of oral microbiome on oral cancers, a review. Biomed Pharmacother. 2016;84:552–558. [DOI] [PubMed] [Google Scholar]
  • 14.Dosseva-Panova VT, Popova CL, Panov VE. Subgingival microbial profile and production of proinflammatory cytokines in chronic periodontitis. Folia Med (Plovdiv). 2014;56:152–160. [DOI] [PubMed] [Google Scholar]
  • 15.Kassebaum NJ Bernabé E Dahiya M, et al. Global burden of severe periodontitis in 1990–2010: a systematic review and meta-regression. J Dent Res. 2014;93:1045–1053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Meyer MS Joshipura K Giovannucci E, et al. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008;19:895–907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lee K Lee JS Kim J, et al. Oral health and gastrointestinal cancer: a nationwide cohort study. J Clin Periodontol. 2020;47:796–808. [DOI] [PubMed] [Google Scholar]
  • 18.Liberati A Altman DG Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Stang A. Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605. [DOI] [PubMed] [Google Scholar]
  • 20.Hu J Dong Y Chen X, et al. Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies. Compr Psychiatry. 2015;61:78–89. [DOI] [PubMed] [Google Scholar]
  • 21.Melsen WG Bootsma MC Rovers MM, et al. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014;20:123–129. [DOI] [PubMed] [Google Scholar]
  • 22.Chen GC Zhang ZL Wan Z, et al. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis. Cancer Causes Control. 2015;26:1719–1728. [DOI] [PubMed] [Google Scholar]
  • 23.Egger M Davey Smith G Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101. [PubMed] [Google Scholar]
  • 25.Duval S, Tweedie R. Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463. [DOI] [PubMed] [Google Scholar]
  • 26.Hujoel PP Drangsholt M Spiekerman C, et al. An exploration of the periodontitis-cancer association. Ann Epidemiol. 2003;13:312–316. [DOI] [PubMed] [Google Scholar]
  • 27.Michaud DS Joshipura K Giovannucci E, et al. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst. 2007;99:171–175. [DOI] [PubMed] [Google Scholar]
  • 28.Michaud DS Liu Y Meyer M, et al. Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study. Lancet Oncol. 2008;9:550–558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hiraki A Matsuo K Suzuki T, et al. Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol Biomarkers Prev. 2008;17:1222–1227. [DOI] [PubMed] [Google Scholar]
  • 30.Arora M Weuve J Fall K, et al. An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-twin study. Am J Epidemiol. 2010;171:253–259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 2012;33:1055–1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ansai T Takata Y Yoshida A, et al. Association between tooth loss and orodigestive cancer mortality in an 80-year-old community-dwelling Japanese population: a 12-year prospective study. BMC Public Health. 2013;13:814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wen BW Tsai CS Lin CL, et al. Cancer risk among gingivitis and periodontitis patients: a nationwide cohort study. QJM. 2014;107:283–290. [DOI] [PubMed] [Google Scholar]
  • 34.Huang J Roosaar A Axéll T, et al. A prospective cohort study on poor oral hygiene and pancreatic cancer risk. Int J Cancer. 2016;138:340–347. [DOI] [PubMed] [Google Scholar]
  • 35.Chang JS Tsai CR Chen LT, et al. Investigating the association between periodontal disease and risk of pancreatic cancer. Pancreas. 2016;45:134–141. [DOI] [PubMed] [Google Scholar]
  • 36.Michaud DS Kelsey KT Papathanasiou E, et al. Periodontal disease and risk of all cancers among male never smokers: an updated analysis of the Health Professionals Follow-up Study. Ann Oncol. 2016;27:941–947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nwizu NN Marshall JR Moysich K, et al. Periodontal disease and incident cancer risk among postmenopausal women: results from the Women's Health Initiative Observational Cohort. Cancer Epidemiol Biomarkers Prev. 2017;26:1255–1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Chou SH Tung YC Wu LS, et al. Severity of chronic periodontitis and risk of gastrointestinal cancers: a population-based follow-up study from Taiwan. Medicine (Baltimore). 2018;97:e11386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Heikkilä P But A Sorsa T, et al. Periodontitis and cancer mortality: register-based cohort study of 68,273 adults in 10-year follow-up. Int J Cancer. 2018;142:2244–2253. [DOI] [PubMed] [Google Scholar]
  • 40.Gerlovin H Michaud DS Cozier YC, et al. Oral health in relation to pancreatic cancer risk in African American women. Cancer Epidemiol Biomarkers Prev. 2019;28:675–679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Babic A Poole EM Terry KL, et al. Periodontal bone loss and risk of epithelial ovarian cancer. Cancer Causes Control. 2015;26:941–947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Maisonneuve P, Amar S, Lowenfels AB. Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis. Ann Oncol. 2017;28:985–995. [DOI] [PubMed] [Google Scholar]
  • 43.Iodice S Gandini S Maisonneuve P, et al. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008;393:535–545. [DOI] [PubMed] [Google Scholar]
  • 44.Samokhvalov AV, Rehm J, Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine. 2015;2:1996–2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wang YT Gou YW Jin WW, et al. Association between alcohol intake and the risk of pancreatic cancer: a dose-response meta-analysis of cohort studies. BMC Cancer. 2016;16:212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Garrett WS. Cancer and the microbiota. Science. 2015;348:80–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Muto M Hitomi Y Ohtsu A, et al. Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: implications for carcinogenesis in upper aerodigestive tract. Int J Cancer. 2000;88:342–350. [PubMed] [Google Scholar]
  • 49.Kurkivuori J Salaspuro V Kaihovaara P, et al. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol. 2007;43:181–186. [DOI] [PubMed] [Google Scholar]
  • 50.Yang L Ganly I Morris L, et al. Relevance of microbiome to cigarette smoking and oral cancer. San Diego, CA: Paper presented at: IADR General Session. March 16–19, 2011. Available at: https://iadr.abstractarchives.com/abstract/2011sandiego-147104/relevance-of-microbiome-to-cigarette-smoking-and-oral-cancer. [Google Scholar]
  • 51.Behrens G Jochem C Schmid D, et al. Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2015;30:279–298. [DOI] [PubMed] [Google Scholar]
  • 52.Loesche WJ. Association of the oral flora with important medical diseases. Curr Opin Periodontol. 1997;4:21–28. [PubMed] [Google Scholar]
  • 53.Chauncey HH Muench ME Kapur KK, et al. The effect of loss of teeth on diet and nutrition. Int Dent J. 1984;34:98–104. [PubMed] [Google Scholar]
  • 54.van der Bilt A Olthoff LW Bosman F, et al. The effect of missing postcanine teeth on chewing performance in man. Arch Oral Biol. 1993;38:423–429. [DOI] [PubMed] [Google Scholar]
  • 55.Slagter AP, Bosman F, Van der Bilt A. Comminution of 2 artificial test foods by dentate and edentulous subjects. J Oral Rehabil. 1993;20:159–176. [DOI] [PubMed] [Google Scholar]
  • 56.Rebours V Boutron-Ruault MC Jooste V, et al. Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses. Am J Gastroenterol. 2009;104:2312–2317. [DOI] [PubMed] [Google Scholar]

Articles from Pancreas are provided here courtesy of Wolters Kluwer Health

RESOURCES